1. Home
  2. NRXP vs PXLW Comparison

NRXP vs PXLW Comparison

Compare NRXP & PXLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • PXLW
  • Stock Information
  • Founded
  • NRXP 2015
  • PXLW 1997
  • Country
  • NRXP United States
  • PXLW United States
  • Employees
  • NRXP N/A
  • PXLW N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • PXLW Semiconductors
  • Sector
  • NRXP Health Care
  • PXLW Technology
  • Exchange
  • NRXP Nasdaq
  • PXLW Nasdaq
  • Market Cap
  • NRXP 32.6M
  • PXLW 37.6M
  • IPO Year
  • NRXP N/A
  • PXLW 2000
  • Fundamental
  • Price
  • NRXP $3.05
  • PXLW $8.98
  • Analyst Decision
  • NRXP Strong Buy
  • PXLW Strong Buy
  • Analyst Count
  • NRXP 4
  • PXLW 2
  • Target Price
  • NRXP $28.50
  • PXLW $15.00
  • AVG Volume (30 Days)
  • NRXP 188.0K
  • PXLW 78.4K
  • Earning Date
  • NRXP 08-13-2025
  • PXLW 08-06-2025
  • Dividend Yield
  • NRXP N/A
  • PXLW N/A
  • EPS Growth
  • NRXP N/A
  • PXLW N/A
  • EPS
  • NRXP N/A
  • PXLW N/A
  • Revenue
  • NRXP N/A
  • PXLW $34,246,000.00
  • Revenue This Year
  • NRXP N/A
  • PXLW $5.21
  • Revenue Next Year
  • NRXP N/A
  • PXLW $35.68
  • P/E Ratio
  • NRXP N/A
  • PXLW N/A
  • Revenue Growth
  • NRXP N/A
  • PXLW N/A
  • 52 Week Low
  • NRXP $1.10
  • PXLW $4.67
  • 52 Week High
  • NRXP $6.01
  • PXLW $14.16
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 43.40
  • PXLW 64.13
  • Support Level
  • NRXP $3.12
  • PXLW $6.71
  • Resistance Level
  • NRXP $3.53
  • PXLW $9.92
  • Average True Range (ATR)
  • NRXP 0.16
  • PXLW 0.55
  • MACD
  • NRXP -0.07
  • PXLW 0.14
  • Stochastic Oscillator
  • NRXP 3.92
  • PXLW 59.19

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About PXLW Pixelworks Inc.

Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.

Share on Social Networks: